AA amyloidosis complicating cryopyrin-associated periodic syndrome: a study of 86 cases including 23 French patients and systematic review
Authors:
- 9 March 2022
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 61 (12) , 4827-4834
Abstract
Objective: Cryopyrin-associated periodic syndrome (CAPS) is a rare but treatable inherited autoinflammatory condition including familial cold autoinflammatory syndrome (FCAS), Muckle–Wells syndrome (MWS) and chronic infantile neurologic cutaneous articular syndrome (CINCA). Our objective was to describe the main features of CAPS AA amyloidosis (AA-CAPS) associated and the efficacy of IL-1 inhibitors in this indication. Methods: Retrospective study in France associated with a systematic literature review. Results: Eighty-six patients were identified: 23 new French cases and 63 from the literature, with a median age at amyloidosis diagnosis of 39 years old. CAPS subtypes were MWS (n = 62), FCAS (n = 9), frontier forms between MWS and FCAS (n = 12) and between CINCA and MWS (n = 3). NLRP3 had been sequenced in 60 patients (70%) and the most frequent mutation was R260W (60%). Three AA-CAPS patients displayed somatic NLRP3 mutations. Death occurred in 35 patients (41%), none of whom having ever received IL-1 inhibitors. Twenty-eight patients (33%) received IL-1 inhibitors, with a >50% decrease in proteinuria in 89% of cases. Conclusion: AA amyloidosis can occur in nearly all CAPS subtypes. IL-1 inhibitors are effective, underlining the necessity of an early diagnosis of CAPS in order to start this treatment as soon as possible among AA-CAPS patients.Keywords
This publication has 12 references indexed in Scilit:
- Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic reviewCritical Reviews in Clinical Laboratory Sciences, 2018
- Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever RegistryAnnals of the Rheumatic Diseases, 2015
- Recommendations for the management of autoinflammatory diseasesAnnals of the Rheumatic Diseases, 2015
- Brief Report: AA Amyloidosis Complicating the Hereditary Periodic Fever SyndromesArthritis & Rheumatism, 2012
- Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndromeJoint Bone Spine, 2010
- Cryopyrinopathies: update on pathogenesis and treatmentNature Clinical Practice Rheumatology, 2008
- Natural History and Outcome in Systemic AA AmyloidosisNew England Journal of Medicine, 2007
- The clinical continuum of cryopyrinopathies: Novel CIAS1 mutations in North American patients and a new cryopyrin modelArthritis & Rheumatism, 2007
- Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinraArthritis & Rheumatism, 2004
- The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean feverArthritis & Rheumatism, 2003